GURU.Markets stock price, segment price, and overall market index valuation
The company's share price WST
The West Pharmaceutical Services chart tells a story of growing demand for high-quality components for injectable medications. The stock price moves in sync with pharmaceutical innovation, tightening standards, and increased production of vaccines and biologics worldwide.
Share prices of companies in the market segment - Medical instruments
West Pharmaceutical is a key supplier of injectable packaging components. We classify it as part of the Medical Instruments sector. The chart below shows the overall dynamics of this segment, which is growing alongside the global biopharmaceuticals and vaccines market.
Broad Market Index - GURU.Markets
West Pharmaceutical Services is a leading manufacturer of packaging components and injectable drug delivery systems, such as stoppers and syringes. As a key supplier to the pharmaceutical industry, the company is included in the GURU.Markets index. The chart below shows the overall market performance. Compare its stock performance to the overall healthcare sector.
Change in the price of a company, segment, and market as a whole per day
WST - Daily change in the company's share price WST
For West, a key manufacturer of components for packaging and delivering injectable medications, daily price changes reflect its sensitivity to pharmaceutical industry demand. While the graph of these fluctuations is unspectacular, it is an important component of formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Medical instruments
The medical devices sector, where West Pharmaceutical Services is a key supplier, has its own dynamics. This chart shows the industry's average daily volatility, serving as a benchmark. By comparing it with WST stock fluctuations, investors can understand how the company's indispensable role in the pharmaceutical supply chain makes it more stable.
Daily change in the price of a broad market stock, index - GURU.Markets
West Pharmaceutical is a leading manufacturer of components for packaging and delivering injectable medications. Its business is closely tied to the healthcare pharmaceutical industry. The chart below illustrates the overall market volatility, which may make West appear more secure.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization WST
West Pharmaceutical is a quiet but critical player in the pharmaceutical industry, producing packaging (syringes, stoppers) for injectable drugs. Its year-over-year performance reflects the steady growth of the global pharmaceutical market, as illustrated by the chart below.
Annual dynamics of market capitalization of the market segment - Medical instruments
West Pharmaceutical Services, Inc. is a key supplier of packaging components and delivery systems for injectable medications. Its products are critical to the pharmaceutical industry, ensuring stable demand. The chart below shows how its indispensable role in the healthcare supply chain drives its accelerated growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
West Pharmaceutical Services is a leading manufacturer of packaging components and injectable drug delivery systems. Its business benefits from the long-term growth of the biopharmaceutical market. This is a stable growth story in the healthcare sector, unaffected by economic cycles.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization WST
West Pharmaceutical Services produces critical components for injectable drug packaging. The monthly fluctuations on the chart reflect the growing market for biotech drugs requiring complex packaging, making the company a key yet under-the-radar player in the pharmaceutical industry.
Monthly dynamics of market capitalization of the market segment - Medical instruments
West Pharmaceutical Services is a critical supplier to the pharmaceutical industry, producing components for injectable drug delivery systems. The dynamics of the medical instrument sector, shown in the graph, reflects general trends in healthcare. This allows us to assess how the growth of the biologics and injectable drug markets directly impacts demand for West products.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Pharmaceutical component suppliers are often viewed as defensive stocks. The chart below shows general market fluctuations. Does West Pharmaceutical Services demonstrate stability, reacting less violently to market downturns due to non-cyclical demand?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization WST
Shares of West Pharmaceutical, a manufacturer of drug delivery systems, react weekly to news from pharmaceutical industry clients. Successful clinical trials or approval of a new drug from a partner directly impact demand for WST products, creating short-term price fluctuations and reflecting the pulse of the biotech sector.
Weekly dynamics of market capitalization of the market segment - Medical instruments
The entire medical component manufacturing sector, including West Pharmaceutical, reacts to industry-wide news on a weekly basis. Regulatory decisions, the size of pharmaceutical giants' R&D budgets, and the overall sentiment in healthcare set the tone for everyone. The chart will show whether WST is moving in unison with its peers or whether it's on its own trajectory.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
West Pharmaceutical is a "shovel supplier" to the pharmaceutical industry, producing packaging for injectable medications. Demand for its products is stable and growing alongside the biotech market. The chart shows how this unnoticed yet essential role ensures the company's shares are less volatile than the overall stock market.
Market capitalization of the company, segment and market as a whole
WST - Market capitalization of the company WST
West Pharmaceutical's market capitalization chart is a barometer of the injectable drug industry. Every increase reflects not only the company's success but also new breakthroughs in biotech, for which its components are critical. It reveals how investors value this indispensable yet invisible giant behind the production of life-saving medications.
WST - Share of the company's market capitalization WST within the market segment - Medical instruments
West Pharmaceutical Services is a key supplier of packaging and delivery systems for injectable medications. The company's market capitalization in the medical equipment segment underscores its indispensable role in the entire pharmaceutical industry. The chart below demonstrates the strength of this critical player.
Market capitalization of the market segment - Medical instruments
To appreciate the value of West Pharmaceutical Services, look at the chart below. It shows the total value of all companies creating medical devices—a vast and steadily growing sector. Its dynamics reflect global investment in healthcare, which makes West's innovations in drug delivery systems particularly significant.
Market capitalization of all companies included in a broad market index - GURU.Markets
The chart below summarizes the value of all companies worldwide. In this universe, West Pharmaceutical Services occupies a special niche. Its market capitalization is based on the production of components for injectable medications. It is an invisible but indispensable part of global healthcare, ensuring the safety and effectiveness of drugs.
Book value capitalization of the company, segment and market as a whole
WST - Book value capitalization of the company WST
West Pharmaceutical's book value is a story about the material embodiment of sterility and safety. Each peak on this chart reflects investments in factories and high-precision equipment for creating flawless packaging for injectables. These are not just assets, but a physical guarantee of quality in the global healthcare chain.
WST - Share of the company's book capitalization WST within the market segment - Medical instruments
West Pharmaceutical's share of the sector's assets reflects its robust manufacturing base. The company controls sterile factories and high-precision equipment, creating the physical foundation for the production of billions of components for injectable medications. This scale creates a high barrier to entry for new players.
Market segment balance sheet capitalization - Medical instruments
West Pharmaceutical Services creates "armor" for injectable medications—vials and delivery systems. This business requires sterile production facilities and sophisticated equipment, which creates a substantial capital base. The book value chart shows how much these assets are worth compared to other players in the medical sector.
Book value of all companies included in the broad market index - GURU.Markets
Behind the physical shell of West Pharmaceutical are factories and high-precision equipment producing billions of sterile injection packages. The graph below is not just numbers, but a visualization of the growth of the physical infrastructure that ensures the safety of global medicine and protects public health.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - WST
West Pharmaceutical's factories have real value, but the market values the company at several times that. This premium is a price for trust. Pharmaceutical giants rely on their sterility, and this intangible asset is priceless. The chart below shows how this "reliability premium" has changed over time.
Market to book capitalization ratio in a market segment - Medical instruments
West Pharmaceutical Services creates critical components for injectable medications, where value lies in patents and technologies. This chart shows how much the company's market valuation exceeds the value of its tangible assets. See how investor expectations for WST compare to the sector average.
Market to book capitalization ratio for the market as a whole
West Pharmaceutical Services creates critical components for injectable medications. Compared to the average market valuation shown in the chart, the company's high value is due not to its factories, but to its patents and deep integration into the pharmaceutical industry. The market factors in its reputation, reliability, and intellectual property, which are barely reflected on the balance sheet.
Debts of the company, segment and market as a whole
WST - Company debts WST
West Pharmaceutical Services, a manufacturer of critical components for injectable drug packaging (such as stoppers and syringes), is using debt to expand its production capacity. The growing biotech market demands high-quality, sterile packaging, and this chart shows how the company is investing to meet this demand.
Market segment debts - Medical instruments
West Pharmaceutical, a key supplier of injection systems, operates in the stable but capital-intensive healthcare sector. Production expansion requires significant investment. This chart shows how aggressively the company leverages its growth compared to competitors in its niche.
Market debt in general
West Pharmaceutical Services, a key supplier to the pharmaceutical industry, uses debt instruments to expand production and make strategic acquisitions. This chart, which reflects the company's overall debt position, allows one to assess how wisely the company manages its capital. For WST, debt is not a risk, but a means to strengthen its leadership position and ensure uninterrupted supplies of critical components.
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio WST
West Pharmaceutical Services is a key supplier of components for injectable medications. This chart shows the debt-to-equity ratio. The debt level may reflect investments in expanding production capacity or R&D. Investors should monitor whether the debt burden becomes a risk if demand from pharmaceutical giants slows.
Market segment debt to market segment book capitalization - Medical instruments
West Pharmaceutical Services is a critical link in the pharmaceutical supply chain, producing injection systems. This sector requires significant investment in sterile manufacturing and innovation. This chart reflects the overall debt level of the industry, which helps us understand how aggressively West's competitors are financing their growth with debt.
Debt to book value of all companies in the market
West Pharmaceutical Services is a manufacturer of injectable drug components operating in the stable healthcare sector. This chart shows the overall leverage of the entire stock market. It allows one to assess whether West's financial policy is more conservative or more aggressive than the average company in the economy, not just among its healthcare peers.
P/E of the company, segment and market as a whole
P/E - WST
West Pharmaceutical Services' commitment to innovation in drug delivery systems and sealed pharmaceutical packaging has raised investor expectations. This chart shows how much the market is willing to pay for each dollar of the company's profit, believing it will play a key role in the future of healthcare, particularly with the growth of complex biologics and vaccines.
P/E of the market segment - Medical instruments
West Pharmaceutical Services is a key, yet often invisible, player in the medical world. The company produces packaging components and delivery systems for injectable drugs, on which pharmaceutical giants depend. How highly does the market value these indispensable suppliers? This chart shows the average valuation for the entire segment, creating a benchmark for comparison with West.
P/E of the market as a whole
West Pharmaceutical Services, which creates components for injectable drugs, operates in a sector where demand is driven by health, not market euphoria. This chart reflects the overall temperature of investor sentiment, but WST's valuation often depends on long-term contracts with pharmaceutical giants rather than short-term fluctuations in investor expectations.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company WST
West Pharmaceutical Services is a quiet giant in the healthcare world, supplying critical components for injectable medications. This chart reflects analysts' expectations for the stability and growth of the pharmaceutical industry. Any new drug requires reliable packaging and delivery systems, so the trend in this indicator is a bet on future innovation and the indispensable role of WST.
Future (projected) P/E of the market segment - Medical instruments
West Pharmaceutical Services produces packaging and delivery systems for injectables, from vials to syringes. This business is critical to the entire pharmaceutical industry. This chart shows how the market views the company's future relative to the medical device sector as a whole, reflecting investor confidence in its stability and technological leadership.
Future (projected) P/E of the market as a whole
West Pharmaceutical Services is a quiet but important supplier of injectable drug delivery systems. This chart reflects the market's overall assessment of its future prospects. In this context, WST's stable, non-cyclical business, focused on the ongoing needs of healthcare, allows investors to view it as a safe haven during periods of general market uncertainty.
Profit of the company, segment and market as a whole
Company profit WST
West Pharmaceutical Services is a key supplier to the pharmaceutical industry, producing injectable drug delivery systems. The company's profitability is directly dependent on the volume of drug and vaccine production worldwide. This chart shows the business's bottom line, which is growing in line with demand for modern medicine and biotechnology.
Profit of companies in the market segment - Medical instruments
West Pharmaceutical Services produces critical components for injectable medications. This chart shows the combined profitability of the medical instrument and pharmaceutical supply chain. For West, this is an indicator of the health of the entire industry: growth here means increased drug production and, consequently, strong demand for their products.
Overall market profit
West Pharmaceutical Services produces critical components for injectable medications: caps, syringes, and delivery systems. It's a shadow healthcare giant on which pharmaceutical companies depend. Its business is less susceptible to economic downturns, as demand for medications is constant. The chart below shows WST's stability amid overall market volatility.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company WST
West Pharmaceutical Services is a critical link in the pharmaceutical industry supply chain, producing injection systems. This chart reflects analysts' expectations for growth in the biologics and vaccines market. Forecast dynamics are directly related to the volume of clinical trials and the launch of new drugs requiring West's high-tech packaging.
Future (predicted) profit of companies in the market segment - Medical instruments
West Pharmaceutical Services plays a key role in the pharmaceutical supply chain, producing packaging and delivery systems for injectables. This segment's profit dynamics are closely tied to innovation in biotech. This chart aggregates analyst expectations across the industry, allowing us to assess how optimistic the market is about the future of medical component manufacturers.
Future (predicted) profit of the market as a whole
West Pharmaceutical is a key player in the global healthcare system, supplying components for drug packaging and administration. This graph, which reflects total market revenue forecasts, allows us to assess how overall economic expectations may impact R&D funding in the pharmaceutical industry and, consequently, demand for the company's products.
P/S of the company, segment and market as a whole
P/S - WST
West Pharmaceutical Services plays a key role in the pharmaceutical industry's supply chain, producing injection systems. This chart shows the premium investors are willing to pay for each dollar of revenue for a company that is fundamentally indispensable to global drugmakers. This high valuation reflects the stability and critical importance of its business.
P/S market segment - Medical instruments
West Pharmaceutical Services is a quiet giant in the medical world, creating critical components for drug delivery systems. This chart shows how the market values the revenue of companies in the sector. By analyzing it, one can understand whether investors consider West's unique position and its contracts with pharmaceutical companies sufficient to warrant a premium above the industry average.
P/S of the market as a whole
West Pharmaceutical Services specializes in innovative packaging solutions and delivery systems for injectable medications. The company's success is directly dependent on pharmaceutical production volumes. The presented graph of overall market revenue estimates allows us to understand how investors generally assess revenue in the economy and, against this backdrop, analyze WST's prospects.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company WST
West Pharmaceutical Services is an indispensable partner for global pharmaceutical giants, producing injectable drug delivery systems. This chart provides a glimpse into the future, showing how the market values the company relative to its projected sales. A high valuation may indicate growth expectations driven by the launch of new drugs.
Future (projected) P/S of the market segment - Medical instruments
West Pharmaceutical Services occupies a unique position as a supplier of injectable drug delivery systems. Their future sales are closely tied to the success of biotech and pharma giants. This chart shows how investors view their role as an indispensable partner in the drug development chain compared to other medical device manufacturers.
Future (projected) P/S of the market as a whole
West Pharmaceutical Services creates critical components for injectable medications, from vials to syringes. Their business is directly linked to the health of the pharmaceutical industry. This chart, measuring overall market revenue growth expectations, shows how confident investors are in the success of new drugs. For WST, this means potential growth in orders for their delivery systems.
Sales of the company, segment and market as a whole
Company sales WST
West Pharmaceutical Services is a quiet but critical link in the global healthcare system. The company produces components for packaging and delivery systems for injectable medications. This chart reflects demand from pharmaceutical giants: increased production of vaccines or biologics directly increases orders for West's products, making revenue an indicator of the health of the entire industry.
Sales of companies in the market segment - Medical instruments
West Pharmaceutical Services is a key, albeit invisible, player in the world of big pharma. The company creates high-tech packaging and delivery systems for injectable drugs. This chart details their revenue structure, showing what share of revenue comes from their own proprietary products and what comes from contract manufacturing for industry giants.
Overall market sales
West Pharmaceutical Services plays a key role in the global healthcare system, producing components for drug packaging and delivery. The robust demand for its products, from syringes to complex drug delivery systems, is directly linked to the overall health of the industry. This chart reflects overall economic activity, where WST plays a vital role in the value chain.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company WST
West Pharmaceutical Services is an indispensable partner for pharmaceutical giants, supplying components for injectable medications. The trend in this chart shows analysts' estimates of future demand for the company's products. Increased forecasts are often linked to the expected increase in vaccine production and the launch of new biotech drugs worldwide.
Future (projected) sales of companies in the market segment - Medical instruments
West Pharmaceutical Services is a key link in the injectable drug supply chain, creating packaging and delivery systems for pharmaceutical companies. This chart reflects the aggregated analyst expectations for the entire medical device and pharmaceutical packaging sector. This allows us to assess whether WST's business will face a tailwind or a headwind in the near future.
Future (projected) sales of the market as a whole
The success of West Pharmaceutical Services, a supplier of injectable drug components, is closely tied to the overall health care and pharmaceutical industry. This chart, which displays market sales forecasts, helps assess future demand for medical services and, consequently, for the company's products, which are an integral part of the supply chain for many vital medications.
Marginality of the company, segment and market as a whole
Company marginality WST
West Pharmaceutical Services' success in manufacturing components for drug delivery systems is directly reflected in this chart. High profitability is driven by demand for proprietary products, such as syringes and closure systems, which are critical to drug safety and efficacy, allowing the company to dictate prices and control costs.
Market segment marginality - Medical instruments
West Pharmaceutical Services is a key supplier of injection drug delivery systems, from syringes to vials. Success in this field depends on the highest manufacturing precision and adherence to strict standards. The metrics in this chart reflect the company's operational efficiency. Comparing them to industry averages reveals a competitive advantage in cost management and pricing.
Market marginality as a whole
West Pharmaceutical Services produces critical components for injectable medications. Demand for its products is driven not by economic cycles, but by healthcare needs and the R&D activities of pharmaceutical companies. This graph of overall market profitability allows us to assess the stability and non-cyclical nature of West's business, growing in line with medical innovation.
Employees in the company, segment and market as a whole
Number of employees in the company WST
West Pharmaceutical Services' workforce reflects its role in global healthcare. The company manufactures systems for the safe delivery of injectable medications, from syringes to vial components. This chart shows the size of the team that ensures the sterility and reliability of products for pharmaceutical giants, directly impacting the safety of millions of patients worldwide.
Share of the company's employees WST within the market segment - Medical instruments
West Pharmaceutical Services is a key link in the global pharmaceutical supply chain, producing components for injectable medications. This chart reflects not just the headcount but the scale of the company's responsibility. It shows the proportion of specialists in the segment, from engineers to cleanroom operators, who ensure the safety and efficacy of billions of doses of vaccines and medications worldwide.
Number of employees in the market segment - Medical instruments
West Pharmaceutical Services is a key link in the injectable drug supply chain. The company manufactures syringe and vial components, ensuring the safety and efficacy of medications worldwide. This chart illustrates the number of specialists involved in this critical segment, the dynamics of which are directly linked to the growth of the global pharmaceutical and biotech industries.
Number of employees in the market as a whole
West Pharmaceutical Services plays a behind-the-scenes but critical role in global medicine, creating components for packaging and delivering injectable medications. The overall employment dynamics shown in this chart indirectly reflect the state of the economy, which impacts healthcare and pharmaceutical company budgets. An increase in the number of employees in the market often correlates with increased investment in new drugs, directly increasing demand for WST products.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company WST (WST)
West Pharmaceutical Services produces critical components for injectable medications, such as stoppers and syringes. This graph demonstrates how the market values each of the company's employees. This reflects a business model based on intellectual property, strict quality standards, and deep integration with the pharmaceutical industry, where value is created through technology, not mass labor.
Market capitalization per employee (in thousands of dollars) in the market segment - Medical instruments
West Pharmaceutical Services specializes in critical components for injectables, such as closures and seals. It's a high-tech industry with high barriers to entry. This chart shows the average market capitalization per employee in the industry. Comparing this helps us understand whether West's market value, based on its technology, is high or low relative to its manufacturing workforce.
Market capitalization per employee (in thousands of dollars) for the overall market
West Pharmaceutical Services creates high-tech components for injectables, such as syringes and drug delivery systems. This chart shows how the market values the company's intellectual capital and production efficiency per employee. High values indicate a premium for innovation and its role in the global pharmaceutical industry.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company WST (WST)
West Pharmaceutical Services specializes in the production of critical components for injectable medications. This chart shows how efficiently the company converts its high-tech manufacturing process into net profit per employee. Their business is a balance between R&D, rigorous quality control, and scalable manufacturing.
Profit per employee (in thousands of dollars) in the market segment - Medical instruments
West Pharmaceutical Services is a B2B company that creates critical components (syringes, seals) for injectable medications. This chart shows the industry average. The Medical Instruments sector traditionally has high labor profitability. This business is built on R&D, patents, and the highest quality standards, which ensures high margins.
Profit per employee (in thousands of dollars) for the market as a whole
West Pharmaceutical Services creates high-tech components for injectable medications. This graph, reflecting the average value of one employee in the market, helps assess the research intensity of their business. Here, a small number of engineers and cleanroom operators, working with complex equipment, can generate profits comparable to thousands of workers in other industries.
Sales to employees of the company, segment and market as a whole
Sales per company employee WST (WST)
West Pharmaceutical Services is a key player in the production of injectable drug delivery systems. This chart reflects how effectively the company converts its intellectual capital and advanced manufacturing processes into revenue. Every employee contributes to the creation of high-tech products that are critical to the global pharmaceutical industry.
Sales per employee in the market segment - Medical instruments
West Pharma produces complex drug delivery systems. This high-tech production facility, where the balance between innovation and automation determines profitability, is crucial. This chart shows how efficiently the company utilizes its personnel to generate revenue compared to other medical device manufacturers. High R&D costs may temporarily reduce this metric, but in the long term, they drive value.
Sales per employee for the market as a whole
West Pharmaceutical Services is an "invisible" giant in the pharmaceutical world. They produce high-tech delivery systems: syringes, plungers, and injection seals. Every time a vaccine or injection is administered, there's a chance it passes through one of their components. This graph shows how much revenue their team generates by selling billions of dollars worth of critical, high-margin components to the pharmaceutical industry.
Short shares by company, segment and market as a whole
Shares shorted by company WST (WST)
West Pharmaceutical (WST) is a key player in the drug delivery industry, producing injection components (syringes, stoppers). Their business is closely tied to the health of the pharmaceutical industry. This chart shows how many investors are betting on WST's decline. The high volume of such bets may reflect concerns about the stability of demand for their products after the pandemic or a perception of intense competition.
Shares shorted by market segment - Medical instruments
West Pharmaceutical Services (WST) creates critical components for drug delivery systems, such as syringes and seals. Their business depends on the health of the pharmaceutical industry. This chart shows the overall bearish sentiment across the entire segment. It reflects how many investors are betting on a decline in the medical instruments sector as a whole, not just WST.
Shares shorted by the overall market
West Pharmaceutical Services produces components for packaging and delivering injectable medications (syringes, stoppers). It is a critical supplier for pharmaceutical companies. This indicator of general market pessimism usually has little impact on WST, as its business is protected. However, if panic is widespread, investors may sell even these companies, locking in profits in shares that have risen sharply.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator WST (WST)
West Pharmaceutical Services supplies components for drug packaging and delivery and is closely linked to the pharmaceutical industry. A level above 70 may reflect strong growth in drug production or success for WST's clients. A level below 30 may signal concerns about a slowdown in pharmaceutical R&D or a general decline in the healthcare market.
RSI 14 Market Segment - Medical instruments
West Pharmaceutical Services (WST) plays a behind-the-scenes but critical role in medicine, producing injectable drug delivery systems (syringes, vials). Their business is growing with the development of biotech. This chart measures the pulse of the entire Medical Instruments sector. It helps separate WST's own success from the overall industry trend—is the entire segment overheated by expectations of medical breakthroughs?
RSI 14 for the overall market
West Pharmaceutical (WST) is an "unsung hero" of the pharmaceutical industry. They produce critical components for injectable medications (such as caps and syringes). This chart shows the overall market "temperature." WST is a "defensive" growth stock. During times of panic, demand for their products remains strong, which may appeal to investors seeking stability in the healthcare sector.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast WST (WST)
West Pharmaceutical (WST) is a quiet giant that produces critical components (syringes, stoppers) for injectable medications. It's a gold mine in the biotech world. This chart shows analyst consensus forecasts. Their optimism or pessimism depends on growth projections for the injectable drug market, including new vaccines and obesity drugs.
The difference between the consensus estimate and the actual stock price WST (WST)
West Pharmaceutical Services is a quiet but critical player in the healthcare industry. The company produces closure systems (stoppers and plungers) for injectable medications. This chart measures the gap between the current price and the consensus target price. It shows whether experts believe demand from biotech and vaccine makers will continue to grow.
Analyst consensus forecast for stock prices by market segment - Medical instruments
West Pharmaceutical Services is an "invisible" pharmaceutical giant. The company produces critical components for drug packaging, such as vial stoppers and syringes. This chart shows analysts' general expectations for the medical instrument sector. It reflects whether experts believe in growth in the production of complex (injectable) drugs.
Analysts' consensus forecast for the overall market share price
West Pharmaceutical Services (WST) is a quiet but critical player in the pharmaceutical industry. They produce high-tech components for drug delivery: syringes, stoppers, and plungers. Their quality saves lives. This chart shows the overall market sentiment. It reflects analysts' confidence in the stability and growth of the global pharmaceutical industry.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index WST
West Pharmaceutical Services is a critical supplier of picks and shovels to the pharmaceutical industry. They manufacture high-tech delivery systems: closures, seals, and autoinjectors for injectable drugs. This chart is an integral indicator of the global pharmaceutical pipeline, as the shift toward complex biologics (like GLP-1) is driving demand for their components.
AKIMA Market Segment Index - Medical instruments
West Pharmaceutical is the unseen champion in the pharmaceutical industry; the company dominates the production of critical components (caps, plungers, syringes) for injectable drugs (vaccines, GLP-1). This composite metric evaluates companies. The chart shows the sector average. This benchmark: how does West's indispensable (and highly profitable) role differentiate it from the average competitor?
The AKIM Index for the overall market
West Pharmaceutical is a quiet giant in the pharmaceutical industry. The company produces critical components for drug delivery: syringes and vial caps. They are the picks and shovels of biotech. This chart, reflecting the market average, is the backdrop. It helps us assess how WST, a defense business growing alongside the pharmaceutical industry, fits into the overall macroeconomic picture.